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Edited by Ulf-Ingo Fl€uggeAbstract Yeast cadmium factor (Ycf1), an ATP-binding cas-
sette (ABC) protein of the multidrug resistance protein subfam-
ily, is a vacuolar GS-conjugate transporter required for heavy
metal and drug detoxiﬁcation. There is evidence that phosphor-
ylation may play a critical role in the function of ABC
transporters from higher organisms. In this work, the possibility
of Ycf1 phosphorylation was examined using site-directed
mutagenesis. We demonstrate that Ser908 and Thr911, within
the regulatory domain (R domain), are functionally important
for Ycf1 transport activity and likely sites for phosphorylation.
Mutation of these residues to alanine severely impaired the Ycf1-
dependent cadmium detoxiﬁcation capacity and transport
activity, while replacement by acidic residues (mimicking phos-
phorylation) signiﬁcantly suppressed the cadmium resistance and
transport defects. Both in vitro treatment of Ycf1 with alkaline
phosphatase and changes in the electrophoretic mobility of the
S908A, T911A and double mutant S908A/T911A proteins
supported the conclusion that Ycf1 is a phosphoprotein. The
screening of the yeast kinome identiﬁed four protein kinases
aﬀecting cadmium detoxiﬁcation, but none of them was involved
directly in the phosphorylation of Ycf1. Our data strongly
implicate Ycf1 phosphorylation as a key determinant in cadmium
resistance in yeast, a signiﬁcant ﬁnding given that very little is
known about phosphorylation of ABC transporters in yeast.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Yeast cells have developed a variety of detoxiﬁcation
mechanisms to eliminate toxic compounds. In these mecha-
nisms, glutathione S-conjugate (GS-X) pumps, belonging to
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doi:10.1016/j.febslet.2004.10.030an essential role. In Saccharomyces cerevisiae, two proteins,
yeast cadmium factor (Ycf1) [1] and Bpt1 [2], have been
shown to be GS-X pumps that catalyze the transport of
glutathione conjugates into the vacuole [3,4]. Through the
action of these two transporters, cadmium ions, complexed to
GSH, are removed from the cytosol and transported into the
vacuole.
Yeast ABC proteins have been classiﬁed into six subfamilies
on the basis of phylogenetic analysis and sequence compari-
sons [5–7]. Ycf1p belongs to one of these, the multidrug re-
sistance protein (MRP) subfamily, together with Bpt1, Ybt1
[8], Vmr1p (Wawrzycka, D., unpublished), all of them showing
vacuolar membrane localization, Yor1 [9], located at the
plasma membrane, and Nft1, recently shown to code for a new
MRP-type transporter [10].
Members of the MRP subfamily of transporters show two
features that distinguish them from other ABC proteins.
First, all yeast MRPs except for Yor1 show an approximately
200 amino acid residue N-terminal extension. In the case of
Ycf1, this N-terminal region is proteolytically processed in a
Pep4-dependent manner [11], and is required both for vacu-
olar traﬃcking and transport activity [12], providing a con-
venient marker for its vacuolar localization. The second
feature, common to the MRP and cystic ﬁbrosis transmem-
brane conductance regulator (CFTR) subfamilies, is the
presence of an additional hydrophilic domain that, because of
a limited but signiﬁcant homology with the regulatory do-
main of CFTR (R domain), has been designated CFTR-like
‘‘regulatory’’ domain or R domain. The regulatory signiﬁ-
cance of the R domain in CFTR is well established and
several serine residues within it have been shown to be re-
quired for the channel activation by cAMP-dependent pro-
tein kinase (PKA) [13]. Ycf1 and its close homolog Bpt1
show the dibasic consensus sequence R[R/K]X[S/T] in the R
domain, corresponding to RRAS908 in Ycf1 and RRAS931 in
Bpt1. On the basis of the cadmium sensitivity of a S908A
mutant of YCF1, it was proposed that Ser908 could be a site
of PKA phosphorylation [1]. In the present work, we have
studied the transport activity of a S908A Ycf1 mutant protein
and have examined the role of PKA.
Our results demonstrate that the phosphorylation of the
Ser908 residue is necessary for Ycf1 transport activity of glu-
tathione conjugates into vacuolar membrane vesicles and
suggest that PKA is not the kinase responsible for this phos-
phorylation. Furthermore, the results presented here show that
Thr911 phosphorylation is also required for cadmium detoxi-blished by Elsevier B.V. All rights reserved.
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involvement of still another kinase in the regulation of the
Ycf1 protein by phosphorylation. Eﬀorts aimed at the identi-
ﬁcation of the protein kinases involved in Ycf1 phosphoryla-
tion are also discussed.2. Materials and methods
2.1. Yeast strains and growth media
The strains used areDycf1 derivatives of the S. cerevisiae strainW303-
1A (MATa ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 ycf1:: URA3),
described in [14], except for experiments with the pka mutant where
strains S7-7A (MATa his3 leu2 ura3 trp1 ade8 tpk2::HIS3 tpk3::TRP1)
and S18-1D (S7-7A tpk1w1) were used [15]. The EUROSCARF mutant
strains were constructed in the BY4741 strain background. Yeast were
grown at 30 C on glucose minimal medium (SD) containing 6.7 g/l
yeast nitrogen base without amino acids and 2% glucose. SD medium
was supplemented with the appropriate requirements (added at 0.1 mg/
ml). Solid media for Cd2þ resistance assays contained 2% agar and was
supplemented with drop-out complete mix (SC).
2.2. Site-directed mutagenesis
Point mutations were constructed by one-step PCR, using the Quick-
change II site-directed mutagenesis kit (Stratagene) following the
manufacturers instructions. A 2.1 kb YCF1 StuI–SalI fragment was
cloned into pSL301 (Invitrogen) and mutagenic oligonucleotides were
designed to create the desired changes. All YCF1 mutant fragments
subjected to mutagenesis were sequenced and used as a source to ex-
change the StuI–SalI fragment with the wild-type fragment. The
plasmids used for the exchange, pRS315 [16] and pRS425 [17] carrying
a hemagglutinin (HA)-tagged version of YCF1, have been described
[14]. All plasmids were sequenced to verify the exchange. The resultant
plasmids, containing either wild-type or mutant YCF1, were trans-
formed into the appropriate strain.
2.3. Cadmium resistance assays
Qualitative and quantitative determinations of Cd2þresistance were
performed essentially as described [14]. Cells were cultured for two
days in solid medium, suspended in water to an A660 nm of 0.2,
dropped on plates without or with CdCl2, and growth scored after
three days. Determination of the minimal inhibitory concentration
(MIC) was performed in microtiter plates containing medium with
CdCl2 concentrations ranging from 0 to 1 mM, inoculated to a cell
density of 6 105 cells/ml. The optical density of each well was de-
termined after two days. Data were ﬁtted to a sigmoidal dose–response
equation using GraphPad Prism 4.0 Software. The MIC value is de-
ﬁned as the lowest Cd2þ concentration at which prominent inhibition
of cell growth (90–95%) is observed.2.4. Measurement of [3H]LTC4 uptake
Standard uptake experiments were performed as described [18].
Brieﬂy, uptake was measured at 30 C in TS buﬀer (250 mM sucrose, 25
mMTris–MES, pH 8.0) containing 4 mMATP, 10 mMMgCl2, 10 mM
creatine phosphate, 20 units/ml creatine kinase, and 50 nM [3H]LTC4
(13 nCi/pmol) in a ﬁnal volume of 55 ll. Uptake was initiated by the
addition of vesicles (10 lg of protein). Aliquots (10 ll) were removed,
diluted in 1 ml of ice-cold TS buﬀer, ﬁltered through nitrocellulose
ﬁlters (pore size 0.45 lm, Millipore, Bedford, MA) and washed twice
with 5 ml of ice-cold TS buﬀer. The retained radioactivity was counted
and initial rates were calculated from the ﬁrst 1.5 min of uptake.2.5. Vacuolar membrane preparation and immunoblot analysis
Vacuolar membrane-enriched fraction was prepared from spherop-
lasts lysates as described in [18]. For immunoblot analysis, upper
gradient fractions of 230 ll were collected, subjected to trichloroacetic
acid precipitation as in [19], the protein solubilized in sample buﬀer [20]
for 15 min at 37 C, resolved by 8% SDS–PAGE, transferred to nylon
membranes and blots probed with the anti-HA monoclonal antibody.
During alkaline phosphatase treatment, a mixture of protease inhibi-
tors (1lg/ml of each aprotinin and leupeptin, 0.1lg/ml pepstatin and
1mM PMSF) was added.3. Results and discussion
3.1. Ycf1 residue Ser908 is essential for cadmium resistance in
vivo and transport activity in vitro
The predicted amino acid sequence of Ycf1 revealed a
putative phosphorylation site, RRAS908 in the R domain,
compatible with the consensus phosphorylation site of PKA.
Mutation of the serine in this sequence to alanine, a non-
phosphorylatable amino acid, was shown to negatively aﬀect
yeast Cd2þ resistance [1]. To further investigate the role of
this putative phosphorylation site on the function of Ycf1,
we generated by site-directed mutagenesis new mutants, in
addition to S908A, in which Ser908 was replaced by either
aspartate (S908D) or glutamate (S908E). The latter residues
could potentially mimic the phosphorylated serine, due to
the negatively charged carboxyl group. The functionality of
the mutant proteins was tested in vivo by assessing their
capacity to allow growth in a Cd2þ containing medium. The
ability of a S908T mutant protein to detoxify Cd2þ was also
analyzed. This mutation, Ser908 to the phosphorylatable
threonine, was found among the revertants isolated during a
search for intragenic suppressors of the S908A mutation
(Eraso et al., unpublished results). The Cd2þ resistance as-
says (Fig. 1A) showed that the Ser908 to Ala change strongly
impairs the sensitivity of the mutant strain, while mutation
to threonine, aspartate or glutamate produced Ycf1 variants
displaying MIC values close to that of the wild-type protein.
These data show that Ser908 is an important residue for Ycf1
biological activity and that its function can be mimicked by
negatively charged amino acids, suggesting that Ycf1 may be
phosphorylated at position 908. The fact that a mutant
carrying a S908T change was selected as a suppressor of
the defect of the S908A mutation further supports the
conclusion.
Ycf1 activity can be measured in vitro by its capacity to
transport the GS-conjugated leukotriene C4 (LTC4) [14]. To
assess the eﬀect of the changes in Ser908 on the activity of Ycf1,
we measured [H3]LTC4 uptake into vacuolar membrane vesi-
cles prepared from a Dycf1 strain expressing either wild-type
Ycf1 or the diﬀerent mutated versions. The results (Fig. 1A)
showed that [H3]LTC4 uptake was strongly reduced by the
S908A mutation. Thus, the decreased in vivo tolerance to Cd2þ
ions shown by the mutant is paralleled by a decreased activity
of the transporter in vitro. Determination of the Ycf1 trans-
port activity of the variants S908T, S908E and S908D indi-
cated that both the introduction of a negative charge or the
replacement by threonine were able to partially rescue the
deleterious eﬀect of the change to alanine.
The Ser908 mutations could aﬀect the biogenesis of the
protein, its sorting to the vacuolar membrane, or its stability,
thus contributing to the observed eﬀects in cadmium resis-
tance and transport activity. The Ycf1 protein has been
shown to suﬀer a proteolytic cleavage of its N-terminal ex-
tension that is Pep4-dependent and can serve as a marker for
proper vacuolar localization [11,12]. Comparison of the ap-
parent molecular masses of the Ycf1 variants with that of the
wild-type, in total membrane preparations, showed in each
case that correct processing had occurred (data not shown),
indicating correct vacuolar localization. While no signiﬁcant
changes in the amount of Ycf1 in vacuolar membrane prep-
arations were found, the Western blots unexpectedly revealed
the presence of forms of the protein with diﬀering mobility
Fig. 1. Analysis of the activity and the electrophoretic mobility of wild-
type and Ser908 mutants of Ycf1. (A) Cd2þ resistance and LTC4
transport activity of Dycf1 strains expressing the wild-type or the
mutant forms of Ycf1. Dycf1 strain was transformed with empty vector
(Dycf1) or vector harbouring each of the indicated YCF1-HA alleles
(YCF1, S908A, S908T, S908E and S908D). Each strain was dropped
onto SC plates containing the indicated CdCl2 concentrations, grown
for three days and photographed. MIC measurement was performed as
described (see Section 2) after growth on microtiter plates containing
medium with increasing concentrations of CdCl2. MIC value for wild-
type Ycf1-HA was 763 lM. Vacuolar membrane vesicles prepared
from the same strains were incubated with 50 nM [3H]LTC4 and 4 mM
ATP (see Section 2) to determine relative rates of LTC4 transport.
MIC and [3H]LTC4 uptake values shown are the average of two in-
dependent experiments. (B) Immunodetection of Ycf1-HA in Dycf 1
strains expressing the wild-type or the mutant forms of Ycf1. 10 lg of
membrane protein from the indicated mutants was subjected to SDS–
PAGE and immunodetected with anti-HA monoclonal antibody. (C) 5
lg of vacuolar membrane protein from wild-type and S908A was in-
cubated in the absence () lanes) or presence (+ lanes) of 20 U of al-
kaline phosphatase for 1 h at 37 C in the presence of Laemmli
solubilizer, subjected to SDS–PAGE and immunodetected with anti-
HA.
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being phosphorylated at Ser908 producing the slow mobility
form. The introduction of alanine at this position may result
in a dephosphorylated form of the protein with higher mo-
bility. The double band pattern found for the S908A mutant
protein points to the existence of a second modiﬁcation of the
protein. This second modiﬁcation is presumably a phos-
phorylation as indicated by the fact that treatment of the
protein samples with alkaline phosphatase before gel frac-
tionation caused the conversion of the S908A slow migrating
forms to a unique and more rapidly migrating band
(Fig. 1C).
Altogether, these data support the conclusion that Ser908 is
phosphorylated in vivo and that the phosphorylation of this
residue is essential for full activity of Ycf1.3.2. Identiﬁcation of a second Ycf1 phosphorylation site
The double band pattern and its elimination by alkaline
phosphatase treatment suggested the existence of a second
modiﬁcation of the protein. In addition, a match exists be-
tween the sequence in Ycf1 RRAS908(P)DAT911 and the casein
kinase 1a (CK1aÞ type II consensus phosphorylation site S/
T(P)XnS/T(P), where prior phosphorylation at a serine or
threonine residue N-terminal to the CK1a site is required [21].
S. cerevisiae have four casein kinase I (CKI) homologs and one
of them, Yck3, has been recently shown to localize to the
vacuolar membrane [22], making it a candidate for the phos-
phorylation of Ycf1. These observations prompted us to per-
form new site-directed mutagenesis of YCF1 generating four
alleles: T911A, T911D, S908AT911A and S908DT911D.
Plasmids carrying these new YCF1 alleles were transformed
into the Dycf1 strain and the resultant transformants tested for
growth in Cd2þ containing medium. As shown in Fig. 2A, the
Thr911 to Ala change decreases Cd2þ resistance, although to a
lesser extent than the Ser908 mutation, and this decrease is
reverted when Thr911 is replaced by an aspartyl residue.
Among all the variants tested, the mutant carrying the
S908AT911A allele exhibited the lowest cadmium resistance,
while the introduction of aspartyl residues at both 908 and 911
Ycf1 positions reverted the eﬀect of the double mutation to
alanine. To assess the eﬀect of the changes in Thr911 on the
activity of Ycf1, we measured [H3]LTC4 uptake into vacuolar
membrane vesicles prepared from a Dycf1 strain expressing the
wild-type Ycf1 or the diﬀerent versions carrying single changes
at position 911 or double changes at Ser908 and Thr911. The
results (Fig. 2A) showed that [H3]LTC4 uptake was strongly
reduced by the T911A mutation and that this decrease was
partially reverted by the introduction of an aspartyl residue.
Finally, the double mutation of Ser908 and Thr911 to Ala ren-
ders a mutant protein with extremely low transport activity,
while the introduction of aspartyl residues at these two posi-
tions allows for the recovery of the transport activity. These
mutations did not aﬀect protein levels or proper localization at
the vacuolar membrane (Fig. 2B). Interestingly, the change at
position 911 altered the electrophoretic mobility of the Ycf1
protein as the mutation at Ser908 did. T911A-Ycf1 migrated as
a doublet, and, as it can be seen in the immunoblot, the main
band is in this case the upper one. The behavior of the T911A
mutant protein with respect to Cd2þ detoxiﬁcation, [H3]LTC4
transport activity and in gel mobility strongly indicates that
Thr911 is phosphorylated in vivo and that this phosphorylation
aﬀects the activity of the transporter. Moreover, the low de-
toxiﬁcation capacity and transport activity conferred by the
S908A/T911A mutant protein, and its electrophoretic migra-
tion as a single band, reminiscent of the alkaline phosphatase
treated wild-type protein, points to these two Ycf1 residues,
908 and 911, as being the sites whose phosphorylation con-
tributes to full activity of the transporter and to the band
pattern observed in the immunoblots.
3.3. Screening of the complete Saccharomyces cerevisiae
collection of protein kinase viable deletion mutants
To identify the protein kinase/s potentially involved in the
regulation of cadmium detoxiﬁcation, we took advantage of
the EUROSCARF collection of yeast viable deletion mutants
constructed during the systematic gene deletion project. As
pointed out before, the primary sequence surrounding Ser908 in
Ycf1 is compatible with the consensus phosphorylation site of
Fig. 2. Analysis of the activity and the electrophoretic mobility of wild-
type and Ser908 and Thr911 single and double mutants. (A) Cd2þ re-
sistance and LTC4 transport activity of Dycf1 strains expressing the
wild-type or the mutant forms of Ycf1. Dycf1 was transformed with
empty vector (Dycf1) or with vector harboring each of the indicated
YCF1-HA alleles (YCF1, S908A, S908D, T911A, T911D,
S908AT911A and S908DT911D). Each strain was dropped onto SC
plates with increasing CdCl2 concentrations, grown for three days and
photographed. MIC measurement was performed as described (see
Section 2) after growth on microtiter plates containing medium with
increasing concentrations of CdCl2. Vacuolar membrane vesicles pre-
pared from the same strains were incubated with 50 nM [3H]LTC4 and
4 mM ATP (see Section 2) to determine relative rates of LTC4 trans-
port. MIC and [3H]LTC4 uptake values shown are the average of two
independent experiments. (B) Immunodetection of Ycf1-HA in Dycf1
strains expressing the wild-type or the mutant forms of Ycf1. 10 lg of
vacuolar membrane protein from the indicated mutants was subjected
to SDS–PAGE and immunodetected with anti-HA monoclonal anti-
body.
Fig. 3. Analysis of the activity and the electrophoretic mobility of wild-
type and S908A mutant Ycf1 in wild-type and pka attenuated strains.
(A) Cd2þ resistance of wild-type and tpk1w1 strains expressing the wild-
type or the S908A mutant forms of Ycf1. Strains S7/7A and S18/1D
were transformed with empty vector (Dycf1) or with vector harboring
the indicated YCF1-HA alleles (YCF1 and S908A). Each strain was
dropped onto SC plates containing the indicated CdCl2 concentra-
tions, grown for three days and photographed. (B) Immunodetection
of Ycf1-HA in wild-type and tpk1w1 strains expressing the wild-type or
the S908A mutant forms of Ycf1. 5 and 10 lg of vacuolar membrane
protein from the indicated mutants were subjected to SDS–PAGE and
immunodetected with anti-HA monoclonal antibody.
P. Eraso et al. / FEBS Letters 577 (2004) 322–326 325PKA. Therefore, prior to the screening, it was important to
elucidate the implication, if any, of PKA. Since S. cerevisiae
has three A kinase catalytic subunits encoded in the TPK
genes, with greater than 75% identity and redundant for cell
viability, analysis of single mutants would not be informative.
To analyze whether phosphorylation by PKA had any eﬀect
on Ycf1 activity, we sought to correlate the in vivo activity of
PKA with the sensitivity to Cd2þ ions. To this end, we used
two strains containing either a wild-type TPK1 allele (strain
S7-7A) or an attenuated TPK1 allele, tpk1w1 (strain S18-1D),
encoding the sole PKA catalytic subunit. The latter strain is
viable and exhibits undetectable PKA activity [15]. Both
strains were disrupted for YCF1 and transformed with plas-
mids carrying either wild-type YCF1 or the S908A mutant. We
reasoned that if PKA was the kinase phosphorylating Ser908,
we would ﬁnd growth of the attenuated strain in Cd2þ con-
taining medium to be independent of the S908A mutation. We
found, however, that although growth of the attenuated strain
was more aﬀected by increasing Cd2þ concentrations than that
of the control strain, it responded to the presence of the dif-
ferent YCF1 alleles in the same way as the wild-type strain did
(Fig. 3A). In addition, no change in the electrophoretic mo-
bility of Ycf1 was observed in the tpk1w1 strain. These results
suggest that PKA is not the kinase involved in Ycf1 phos-phorylation at position 908. In this regard, it is worth men-
tioning that upon examination of the mapped phosphorylation
sites in several of the yeast PKA substrates, none of them
shows an acidic residue at position +1 of the phosphorylated
serine, as would be the case in the Ycf1 sequence (RRAS908D).
Proteins like FbPase, Adr1, Pyk1, Cki1, Ura7, Opi1 and Sso1,
with well characterized PKA sites, exhibit hydrophobic resi-
dues at this position in most cases. An eﬀect of PKA on YCF1
gene expression was discarded based on the ﬁnding that
comparable amounts of Ycf1 were found in Western blots
performed with vacuolar membranes obtained from both
strains (Fig. 3B).
The complete collection of viable protein kinase mutants was
then checked for cadmium tolerance. We found that four
protein kinase mutants, deleted for YIL042c, YPL150w,
YNR047w and YNL307c/MCK1, respectively, but not the
YCK3 mutant, exhibited altered cadmium sensitivity (data not
shown). If any of the deleted kinases was responsible for
phosphorylating at either Ser908 or Thr911 in Ycf1, we should
ﬁnd that the low ability to detoxify cadmium ions would be
paralelled by an increase in the electrophoretic mobility of Ycf1
and the appearance of the characteristic double-band pattern in
the immunoblots. The results showed, however, that in each
mutant, Ycf1 mobility was indistinguishable from that in the
wild-type strain background (data not shown), indicating that
none of the protein kinases selected in the screening is re-
sponsible for the phosphorylation of Ycf1 at Ser908 or Thr911.
326 P. Eraso et al. / FEBS Letters 577 (2004) 322–326The fact that screening the yeast kinome did not allow the
identiﬁcation of the kinases involved in Ycf1 phosphorylation
suggests that either the kinases are redundant in function or
they are encoded in essential genes.
In summary, our analysis shows that two residues, Ser908
and Thr911, located in the regulatory domain of Ycf1, are
phosphorylated in vivo. The results presented here clearly in-
dicate that Ycf1 phosphorylation at both positions is required
for the biological activity of the transporter.
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